Drug
Desvenlafaxine succinate
Desvenlafaxine succinate is a pharmaceutical drug with 5 clinical trials. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
2
40%
Ph phase_1
1
20%
Ph phase_4
1
20%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(1)
Terminated(1)
Other(3)
Detailed Status
unknown3
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)
Trials by Status
completed120%
terminated120%
unknown360%
Recent Activity
0 active trials
Showing 5 of 5
terminated
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
NCT01353963
unknownphase_4
Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
NCT01974934
unknownphase_3
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
NCT00888862
unknownphase_1
Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers
NCT01101152
completedphase_3
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
NCT01309542
Clinical Trials (5)
Showing 5 of 5 trials
NCT01353963
Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
NCT01974934Phase 4
Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
NCT00888862Phase 3
Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
NCT01101152Phase 1
Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers
NCT01309542Phase 3
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5